advertisement
Li M 17
Showing records 1 to 17 | Display all abstracts from Li M104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu X
Eye 2023; 37: 607-617
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Shen J
International Journal of Ophthalmology 2022; 15: 1231-1239
105102 Activation of lesion projection zone in primary visual cortex is dependent on bilateral central vision loss in patients with end-stage glaucoma
Zhu W
Ophthalmic and Physiological Optics 2022; 42: 1159-1169
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Zhang B
Eye 2023; 37: 607-617
105102 Activation of lesion projection zone in primary visual cortex is dependent on bilateral central vision loss in patients with end-stage glaucoma
Liu T
Ophthalmic and Physiological Optics 2022; 42: 1159-1169
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Li Y; Li M
International Journal of Ophthalmology 2022; 15: 1231-1239
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li X
Eye 2023; 37: 607-617
105102 Activation of lesion projection zone in primary visual cortex is dependent on bilateral central vision loss in patients with end-stage glaucoma
Li M
Ophthalmic and Physiological Optics 2022; 42: 1159-1169
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Liu WX
International Journal of Ophthalmology 2022; 15: 1231-1239
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Li M
Eye 2023; 37: 607-617
105102 Activation of lesion projection zone in primary visual cortex is dependent on bilateral central vision loss in patients with end-stage glaucoma
Sun X; He S
Ophthalmic and Physiological Optics 2022; 42: 1159-1169
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Sun HL
International Journal of Ophthalmology 2022; 15: 1231-1239
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wang Y
Eye 2023; 37: 607-617
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Zhang QP
International Journal of Ophthalmology 2022; 15: 1231-1239
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Dan H; Zhou J
Eye 2023; 37: 607-617
105055 Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats
Yi XN
International Journal of Ophthalmology 2022; 15: 1231-1239
104797 The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Wei Y; Ge K; Li P; Song Z
Eye 2023; 37: 607-617
